Skip to main content

Catherine A Spino

NIH Rank #810
  • Program Leader
  • Top 5% Funded
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 9313677Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • BIOSTATISTICS & OTHER MATH SCI
  • Internal Medicine

NIH Funding · FY2025

Linked Award Amount
$7.1M
Full award amounts, FY2025
Award Records
5
Records listing this PI
Award-Linked Rank
#810
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Catherine A Spino. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Catherine A Spino as a PI. Multi-PI records show the full award amount for context.

  • 5U24DK122927-07U24
    University of Michigan Data Coordinating Center for the Diabetic Foot Consortium
    $3.8M
    award amount
  • 5R33HL158540-05R33
    Phase 1 study of oral epigallocatechin-3-gallate (EGCG) in IPF patients
    $1.8M
    award amount
  • 1U24HL180994-01U24
    2/2 A Phase 2 Study of Elafin (Tiprelestat) for the Treatment of Pulmonary Arterial Hypertension (PAH)
    $936.9K
    award amount
  • 5U24HL145265-06U24
    Prospective tReatment EffiCacy in IPF uSlng genOtype for Nac Selection (PRECISIONS) trial and Molecular Endophenotyping in Idiopathic Pulmonary Fibrosis and Interstitial Lung Diseases study
    $408.1K
    award amount
  • 5P50NS123067-05P50
    Cholinergic mechanisms of attentional-motor integration and gait dysfunction in Parkinson Disease
    $221.6K
    award amount

Award organizations

Organizations that administered FY2025 awards listing Catherine A Spino as a PI.

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    University of Michigan
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    $5M Cumulative Funding
  6. 2024
    Entered Top 50% Nationally
    Ranked #573
  7. 2024
    Entered Top 25% Nationally
    Ranked #573
  8. 2024
    Entered Top 10% Nationally
    Ranked #573
  9. 2024
    Entered Top 5% Nationally
    Ranked #573
  10. 2025
    $10M Cumulative Funding
  11. 2025
    Multi-Institutional Research
    Awards at 2 institutions
  12. 2025
    Program/Center Grant Leader